Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_assertion type Assertion NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_head.
- NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_provenance.
- NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_assertion evidence source_evidence_literature NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_provenance.
- NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_assertion SIO_000772 20389136 NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_provenance.
- NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_assertion wasDerivedFrom befree-20140225 NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_provenance.
- NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_assertion wasGeneratedBy ECO_0000203 NP787712.RAIs3lQgNdVIg906qq4RVlpH8-LMUDbPxmqOFy6qttxcQ130_provenance.